Two Sigma Advisers
CRDF icon

Two Sigma Advisers’s Cardiff Oncology CRDF Stock Holding History

Two Sigma Advisers’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-360,500
Closed -$1.01M – 502
2025
Q4 		$1.01M Buy
360,500
+334,700
+1,297% +$777K ﹤0.01% 1479
2025
Q3 		$53.1K Sell
25,800
-179,800
-87% -$497K ﹤0.01% 2266
2025
Q2 		$648K Buy
205,600
+188,100
+1,075% +$574K ﹤0.01% 1631
2025
Q1 		$55K Buy
17,500
+2,700
+18% +$10.7K ﹤0.01% 2315
2024
Q4 		$64.2K Sell
14,800
-316,400
-96% -$989K ﹤0.01% 2266
2024
Q3 		$884K Buy
331,200
+124,200
+60% +$293K ﹤0.01% 1469
2024
Q2 		$460K Buy
207,000
+185,300
+854% +$698K ﹤0.01% 1915
2024
Q1 		$116K Sell
21,700
-17,500
-45% -$46.5K ﹤0.01% 2291
2023
Q4 		$58K Sell
39,200
-1,800
-4% -$2.18K ﹤0.01% 2389
2023
Q3 		$57K Sell
41,000
-131,800
-76% -$222K ﹤0.01% 2267
2023
Q2 		$254K Buy
172,800
+29,300
+20% +$47.3K ﹤0.01% 2033
2023
Q1 		$237K Sell
143,500
-43,400
-23% -$74.5K ﹤0.01% 2222
2022
Q4 		$262K Sell
186,900
-9,600
-5% -$13.7K ﹤0.01% 2111
2022
Q3 		$303K Sell
196,500
-138,300
-41% -$333K ﹤0.01% 2044
2022
Q2 		$737K Sell
334,800
-179,300
-35% -$300K ﹤0.01% 1744
2022
Q1 		$1.27M Sell
514,100
-150,900
-23% -$534K ﹤0.01% 1500
2021
Q4 		$4M Sell
665,000
-35,800
-5% -$213K 0.01% 867
2021
Q3 		$4.67M Buy
700,800
+35,600
+5% +$224K 0.01% 816
2021
Q2 		$4.42M Buy
665,200
+79,300
+14% +$673K 0.01% 920
2021
Q1 		$5.42M Buy
585,900
+467,600
+395% +$5.68M 0.01% 824
2020
Q4 		$2.13M Buy
+118,300
New +$2.08M 0.01% 1223

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Two Sigma Advisers's CRDF Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 360,500 shares — an estimated $1.01M sold.

Two Sigma Advisers first reported a position in CRDF in Q4 2020 and held it in 21 quarters. The position peaked at $5.42M in Q1 2021. 117 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 360,500 Cardiff Oncology shares in Q1 2026, an estimated $1.01M.
  • Two Sigma Advisers first reported a position in Cardiff Oncology in Q4 2020 and held it in 21 quarters.
  • Two Sigma Advisers's Cardiff Oncology position peaked at $5.42M in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.